Herbalife financials
$12.44−1.27%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.33B | $1.32B | $1.29B | $1.27B | $1.26B | $1.22B | $1.22B | $1.24B | $1.28B | $1.26B | $1.23B | $1.28B |
| Gross profit | $1.03B | $1.03B | $1.00B | $989.5M | $982.2M | $956.5M | $952.2M | $971.6M | $998.0M | $979.3M | $938.9M | $978.1M |
| Gross margin | 77.7% | 77.9% | 77.7% | 77.7% | 78.0% | 78.3% | 78.1% | 78.3% | 77.9% | 77.5% | 76.6% | 76.3% |
| Operating income | $128.3M | $138.4M | $108.3M | $125.8M | $132.6M | $122.8M | $118.3M | $122.1M | $80.4M | $71.9M | $67.3M | $106.7M |
| Net income | -$26.3M | $61.9M | $85.4M | $43.2M | $49.3M | $50.4M | $177.9M | $47.4M | $4.7M | $24.3M | $10.2M | $42.8M |
| Net margin | −2.0% | 4.7% | 6.6% | 3.4% | 3.9% | 4.1% | 14.6% | 3.8% | 0.4% | 1.9% | 0.8% | 3.3% |
| Diluted EPS | $-0.25 | $0.57 | $0.81 | $0.42 | $0.48 | $0.49 | $1.74 | $0.46 | $0.05 | $0.24 | $0.10 | $0.43 |
| EBITDA | $159.7M | $167.8M | $137.6M | $156.5M | $163.1M | $153.5M | $147.3M | $152.7M | $113.0M | $101.1M | $67.3M | $135.1M |
| Operating cash flow | $32.9M | $113.8M | $98.3M | $138.8M | $96.0M | $200.0K | $69.6M | $99.5M | $102.5M | $13.8M | $96.1M | $79.6M |
| Free cash flow | $21.6M | $102.9M | $79.8M | $118.0M | $73.2M | -$18.1M | $43.9M | $72.4M | $66.2M | -$19.1M | $60.8M | $48.5M |
| Diluted shares | 104.5M | 108.4M | 104.9M | 104.0M | 103.3M | 102.2M | 102.1M | 101.9M | 101.7M | 100.7M | 100.7M | 100.4M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $370.5M | $451.2M | $353.1M | $305.5M | $320.9M | $329.4M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $2.02B | $1.99B | $1.99B | $2.02B | $2.14B | $2.50B |
| Total assets | $2.86B | $2.88B | $2.79B | $2.70B | $2.74B | $2.68B |
| Total liabilities | $3.32B | $3.31B | $3.30B | $3.30B | $3.39B | $3.42B |
| Shareholders' equity | -$466.9M | -$434.2M | -$509.4M | -$606.0M | -$654.4M | -$736.0M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology